IPO registrations (S-1, F-1) · Registrants

MyoKardia, Inc.

SEC CIK
1552451 · filings on EDGAR ↗
Name on the registration
MyoKardia Inc
Former names
MyoKardia Inc (2012–2020)
Registration
Form S-1, first filed 2015-09-28, last 2016-09-26; 2 initial registrations, 5 amendments
Outcome
Final prospectus filed 2015-10-29; declared effective 2015-10-28
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
1000 SIERRA POINT PARKWAY, Brisbane, CA 94005
EIN
45-5500552
EDGAR entity type
operating
Insiders and CEO pay
MyoKardia, Inc. on the corporate pages

Offering terms

Proposed price range
$15.00–$17.00 per share (S-1/A filed 2015-10-23)
Final price
$10.00 per share, below the range (424B4 filed 2015-10-29, an initial public offering)
Shares sold
5,437,500
Gross proceeds
$54,375,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol MYOK
Lead underwriters
Credit Suisse (2,310,938 shares); Cowen (1,767,187 shares)
Syndicate
Wells Fargo (815,625); Wedbush Securities (543,750)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 14

FiledFormWhat it isName as filedEDGAR
2015-09-28S-1S-1 (registration)MyoKardia Inc0001193125-15-330059 ↗
2015-10-13S-1/AS-1/A (amendment)MyoKardia Inc0001193125-15-342828 ↗
2015-10-19S-1/AS-1/A (amendment)MyoKardia Inc0001193125-15-346145 ↗
2015-10-23S-1/AS-1/A (amendment)MyoKardia Inc0001193125-15-352130 ↗
2015-10-27S-1/AS-1/A (amendment)MyoKardia Inc0001193125-15-354454 ↗
2015-10-28S-1MEFS-1MEF (added securities)MyoKardia Inc0001193125-15-356568 ↗
2015-10-28EFFECTEFFECT (declared effective)MyoKardia Inc9999999995-15-002897 ↗
2015-10-29424B4424B4 (final prospectus)MyoKardia Inc0001193125-15-356933 ↗
2016-09-16S-1S-1 (registration)MyoKardia Inc0001193125-16-712279 ↗
2016-09-26S-1/AS-1/A (amendment)MyoKardia Inc0001193125-16-719919 ↗
2016-09-27EFFECTEFFECT (declared effective)MyoKardia Inc9999999995-16-005801 ↗
2016-09-28424B4424B4 (final prospectus)MyoKardia Inc0001193125-16-723794 ↗
2017-01-19EFFECTEFFECT (declared effective)MyoKardia Inc9999999995-17-000172 ↗
2017-07-21EFFECTEFFECT (declared effective)MyoKardia Inc9999999995-17-001899 ↗

Prospectus pages read 3

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2015-10-23S-1/Aregistration statement$15.00–$17.004,687,500-Nasdaq MYOK4primary document; range, shares headline, cover names 4document ↗
2015-10-27S-1/Aregistration statement--0primary document; no terms founddocument ↗
2015-10-29424B4final prospectus$10.005,437,500$54,375,000Nasdaq MYOK4primary document; price sentence, shares headline, proceeds table, underwriting table 4, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Bauer JakeOfficerChief Business Officer; See Remarks362015–2020
Chan StevenOfficerSee Remarks42015–2017
Fox Jonathan COfficerChief Medical Officer32015–2016
GIANAKAKOS ANASTASIOSDirector,OfficerCEO and President; CEO, President; President and CEO682015–2020
HOMCY CHARLES JDirector32015–2016
Lambing JosephOfficerSee Remarks192015–2019
LEVIN MARK JTenPercentOwner122015–2018person page Fuzzy
McDowell Robert ScottOfficerChief Scientific Officer; See Remarks; Senior VP, Drug Discovery142015–2020
PERRY MARK LDirector112015–2020
SanofiTenPercentOwner62015–2019
STARR KEVIN PDirector,TenPercentOwner132015–2018
TEPPER ROBERT ITenPercentOwner112015–2018
Third Rock Ventures GP III, L.P.TenPercentOwner32015–2018
Third Rock Ventures GP II, L.P.TenPercentOwner102015–2018
Third Rock Ventures III, L.P.TenPercentOwner32015–2018
Third Rock Ventures II, L.P.TenPercentOwner102015–2018
TOPOL ERICDirector32015–2017
TRV GP III, LLCTenPercentOwner32015–2018
TRV GP II, LLCTenPercentOwner102015–2018
AGARWAL SUNILDirector102016–2020
CRANSTON MARY BDirector122016–2020
Semigran MarcOfficerChief Medical Officer92016–2019
Lee JuneOfficerChief Operating Officer; EVP, Chief Development Officer; See Remarks162017–2019
Popovits Kimberly JDirector92017–2020
YARNO WENDY LDirector102017–2020
Meeker David PDirector92017–2020
LADD CYNTHIA JOfficerGeneral Counsel62018–2020
Harris Taylor C.OfficerChief Financial Officer92018–2020
Fairey WilliamOfficerEVP, Chief Commercial Officer; See Remarks52019–2020
Waynick Denelle JOfficerChief Legal Officer; General Counsel32020

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2015-04-30MyoKardia IncBiotechnology$46,000,001$46,000,00191
2014-08-22MyoKardia IncBiotechnology$10,000,000$10,000,00011

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Business registrationMYOKARDIA, INC.CAState business registriesname and state
Plan sponsorMYOKARDIA INC.FLForm 5500 (employee benefit plans)EIN (EXACT)
Form D issuerMyoKardia IncCAForm D private offeringsCIK (EXACT)
Lobbying clientMYOKARDIACAFederal lobbying (LDA)name and state
Lobbying clientMYOKARDIACAFederal lobbying (LDA)name and state
Patent assigneeMYOKARDIA, INC.CAPatents (USPTO)name and state
SEC filerMyoKardia, Inc.SEC filers (EDGAR)CIK (EXACT)
Trademark ownerMyoKardia, Inc.CATrademarks (USPTO)name and state
Form 5500 plan sponsorMYOKARDIA INC.EIN (EXACT)
Person pageMark J LevinPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, CA first:

More with this interest.

In other datasets, the same topic (Health) in CA:

Interests: Pharmaceutical Preparations · Health